000 | 01012 a2200277 4500 | ||
---|---|---|---|
005 | 20250518000409.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a1178-6930 | ||
024 | 7 |
_a10.2147/OTT.S170736 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRusz, Orsolya | |
245 | 0 | 0 |
_aClinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series. _h[electronic resource] |
260 |
_bOncoTargets and therapy _c2018 |
||
300 |
_a5459-5463 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aKószó, Renáta | |
700 | 1 | _aDobi, Ágnes | |
700 | 1 | _aCsenki, Melinda | |
700 | 1 | _aValicsek, Erzsébet | |
700 | 1 | _aNikolényi, Alíz | |
700 | 1 | _aUhercsák, Gabriella | |
700 | 1 | _aCserháti, Adrienne | |
700 | 1 | _aKahán, Zsuzsanna | |
773 | 0 |
_tOncoTargets and therapy _gvol. 11 _gp. 5459-5463 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2147/OTT.S170736 _zAvailable from publisher's website |
999 |
_c28853062 _d28853062 |